This means it activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, a hormone pathway that helps the body release insulin after eating, which may lead to greater effects on blood sugar and weight loss compared to single GLP-1 agonists
It is reasonable to take both observations seriously as hypotheses, with two cautions: Phase 2 trials are smaller, and the trial populations are not identical to GLP-1 trial populations
Data were acquired in real-time using the DatLab 7 software
Microdosing stretches each prescription further since you use less medication per injection, making it meaningfully cheaper than standard-dose therapy
The form of lipid peroxidation with the result of molecular oxygen conversion to reactive oxygen species (ROS) with various environmental factors, particularly cigarette smoke, alcohol, UV rays, and other oxidants, leads to oxidative stress